🍼 PubMed Studies on Lactobacillus reuteri ATCC PTA 5289 Lactobacillus reuteri ATCC PTA 5289

Citations are updated once a week. Recently added citations may not appear.

35 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
Lactobacillus reuteri ATCC PTA 5289    ? A concerted probiotic activity to inhibit periodontitis-associated bacteria.
PloS one (PLoS One ) Vol: 16 Issue 3 Pages: e0248308
Pub: 2021 Epub: 2021 Mar 5 Authors Jansen PM , Abdelbary MMH , Conrads G ,
Html Article Publication
Lactobacillus reuteri ATCC PTA 5289    ? Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Oral health & preventive dentistry (Oral Health Prev Dent ) Vol: 18 Issue 1 Pages: 1017-1023
Pub: 2020 Feb 12 Epub: 2020 Feb 12 Authors Alforaidi S , Bresin A , Almosa N , Lehrkinder A , Lingström P ,
Publication
Lactobacillus reuteri ATCC PTA 5289    ? Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis.
Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 16189
Pub: 2020 Oct 1 Epub: 2020 Oct 1 Authors Gupta N , Ferreira J , Hong CHL , Tan KS ,
Html Article Publication
Lactobacillus reuteri ATCC PTA 5289    ? Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) NoΒ 1924/2006.
EFSA journal. European Food Safety Authority (EFSA J ) Vol: 18 Issue 3 Pages: e06004
Pub: 2020 Mar Epub: 2020 Mar 6 Authors EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA). , Turck D , Castenmiller J , De Henauw S , Ildico Hirsch-Ernst K , Kearney J , Knutsen HK , Maciuk A , Mangelsdorf I , McArdle HJ , Naska A , Pelaez C , Pentieva K , Thies F , Tsabouri S , Vinceti M , Bresson JL , Sanz Y , Siani A ,
Html Article Publication
Lactobacillus reuteri ATCC PTA 5289    ? The usage of a lactobacilli probiotic in the non-surgical therapy of peri-implantitis: A randomized pilot study.
Clinical oral implants research (Clin Oral Implants Res ) Vol: 31 Issue 1 Pages: 84-92
Pub: 2020 Jan Epub: 2019 Nov 25 Authors Laleman I , Pauwels M , Quirynen M , Teughels W ,
Publication

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)